US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by ...
As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
BioNTech SE BNTX announced that it has entered into a definitive agreement to acquire China-based biotech, Biotheus, to ...
The earnings season is in its final week; giants of nifty and sensex have already posted their Q2 results. Today, their 1181 ...
Onyx Biotec IPO listing: The SME IPO is proposed to list on the NSE SME on Thursday ... The market maker for the Onyx Biotec ...
Biotech stocks can be incredibly attractive for risk-taking investors ... Consider when Nvidia made this list on April 15, ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors.
Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...
The stock is currently trading at just under $27. AVXL: Anavex Life Sciences rounds out the list as another heavily-shorted ...